Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Technical Expert Group On Drug Patent Head Says Conclusion Independent View Of The Panel Khomba Singh NEW DELHI
Two landmark decisions of the European Court of Justice related to cross-border patent infringement cases are examined here.
Two formidable challenges seem to overarch agriculture and food production in this century: how to end hunger and how to keep global warming at a level that will allow humanity and the agroecosystems we depend upon to adapt in a noncatastrophic way.
THIS is the variety of rice without which biryani, the royal gastronomical delight, would not feature so prominantly in the history pages on Mughal influence in India. Aromatic, long-grained, nonsticky are the words that describe it. It is the Basmati. India grows 1.6 million tonnes annually. Two-thirds is exported every year. India claims its traditional knowledge of the climate, the
Securing people
Professor Amar Singh of National Law University, New Delhi on Sunday warned that the danger of bio-piracy and illegal patenting of indigenous knowledge was imminent within the country and beyond.
An August negotiating session on the United Nations Framework Climate Change Convention in Bonn ignited some interesting, albeit expected, sparks around the subject of intellectual property rights.
Plant growth promoters are naturally produced molecules that increase crop yield. Developing them for commercial use is difficult. The Central Institute of Medicinal and Aromatic Plants (CIMAP) received a US patent in May, this year, for developing a promoter, isolated from a medicinal plant. Anil Kumar Singh, Deputy Director of the chemistry division, spoke to Savvy Soumya Misra An ongoing
A study done by the Coalition for Healthy India (CHI), an initiative of the US India Business Council (USIBC), brings the subject of pharmaceutical innovation and drug patents into public discourse.
SWISS major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate Board (IPAB) decision to reject its patent application of blood cancer drug Glivec in India. The case is expected to be heard on Monday.